Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Leads to High Rates of Allogeneic Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial | Zendy

Boglarka Gyurkocza | Zendy; Rajneesh Nath | Zendy; Patrick J. Stiff | Zendy; Edward Agura | Zendy; Mark R. Litzow | Zendy; Benjamin Tomlinson | Zendy; Hannah Choe | Zendy; Sunil Abhyankar | Zendy; Stuart Seropian | Zendy; George L. Chen | Zendy; Parameswaran Hari | Zendy; Zaid AlKadhimi | Zendy; James M. Foran | Zendy; Johnnie J. Orozco | Zendy; Koen van Besien | Zendy; Mitchell Sabloff | Zendy; Partow Kebriaei | Zendy; Camille N. Abboud | Zendy; Moshe Levy | Zendy; Hillard M. Lazarus | Zendy; Sergio Giralt | Zendy; Mark S. Berger | Zendy; Vijay Reddy | Zendy; John M. Pagel | Zendy

Open Access

Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Leads to High Rates of Allogeneic Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial

Author(s) -

Boglarka Gyurkocza,

Rajneesh Nath,

Patrick J. Stiff,

Edward Agura,

Mark R. Litzow,

Benjamin Tomlinson,

Hannah Choe,

Sunil Abhyankar,

Stuart Seropian,

George L. Chen,

Parameswaran Hari,

Zaid AlKadhimi,

James M. Foran,

Johnnie J. Orozco,

Koen van Besien,

Mitchell Sabloff,

Partow Kebriaei,

Camille N. Abboud,

Moshe Levy,

Hillard M. Lazarus,

Sergio Giralt,

Mark S. Berger,

Vijay Reddy,

John M. Pagel

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.575

Subject(s) - medicine , venetoclax , salvage therapy , refractory (planetary science) , transplantation , oncology , randomization , clinical trial , randomized controlled trial , surgery , chemotherapy , leukemia , physics , chronic lymphocytic leukemia , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research